Massey director Dr. Robert Winn among first recipients of the COVID-19 vaccination at VCU Medical Center
VCU Medical Center began COVID-19 vaccinations of its first front-line team members Wednesday afternoon. Robert Winn, M.D., director of VCU Massey Cancer Center, was one of seven people who volunteered to be the first to receive the new vaccine.
This week, VCU Massey Cancer Center and VCU Health System welcomed Katie Barnes, MPA, as vice president of the Cancer Service Line. The Cancer Service Line is a new collaborative model designed to fulfill strategic initiatives for Massey while maintaining close alignment with VCU Health System.
Immune cell identified that drives breast cancer growth could be effective target in novel immunotherapies to treat the disease
New research findings from Paula Bos, Ph.D., published in Cell Reports, identified a type of immune cells that acts as a major driver of breast cancer growth by preventing the accumulation of a specific protein that induces anti-tumor responses. This new knowledge could be utilized for the development of novel immunotherapeutic approaches to treat the disease.
Approximately 200,000 cancer patients are diagnosed with brain metastases each year, yet few treatment options exist because the mechanisms that allow cancer to spread to the brain remain unclear. However, a study recently published in the journal Cancer Cell by VCU Massey Cancer Center scientist Suyun Huang, M.D., Ph.D., offers hope for the development of future therapies by showing how a poorly understood gene known as YTHDF3 plays a significant role in the process.
VCU Massey Cancer Center researcher Paul B. Fisher, M.Ph., Ph.D., FNAI, member of the Cancer Biology research program and Thelma Newmeyer Corman Endowed Chair in Oncology Research at Massey, examines the molecular and biochemical basis of cancer development and metastasis in an effort to translate the science into novel cancer therapies.